CellType

CellType is a Y Combinator-backed company that the agentic drug company. We simulate human biology. The company participated in the Winter 2026 batch of Y Combinator.

CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We're working with Top 10 pharma.

CellType was part of Y Combinator's Winter 2026 cohort, has a team of approximately 2 employees, and is actively operating.